UAE
UAE: Russian vaccine trials reach final phase
Clinical trials of the Russian human adenovirus-based Covid-19 vaccine in the UAE have moved into the final monitoring phase, authorities in the country announced on Thursday.
Following the successful second dose vaccination of 1,000 volunteers, the next step involves monitoring volunteers’ immune response over a period of 180 days.
Findings of the UAE trials will be released by April and amalgamated with promising research findings from other global trials.
Recent interim results from Phase III of clinical trials of the Russian human adenovirus-based vaccine, as reported in leading international medical journal The Lancet, showed high efficacy of 91.6 per cent, as well as strong immunogenicity and safety results.
